Electronic patient-reported outcome

From WikiMD's Food, Medicine & Wellness Encyclopedia

Electronic Patient-Reported Outcome (ePRO) is a method of capturing patient's self-reported health status electronically. These outcomes can include symptoms, functional status, and quality of life. ePROs are increasingly being used in clinical trials and healthcare settings to provide a more accurate and reliable measure of patient outcomes.

Overview[edit | edit source]

ePROs are typically collected through electronic devices such as smartphones, tablets, or computers. The use of electronic devices allows for real-time data collection and immediate access to patient responses. This can help healthcare providers to monitor patient health and make timely decisions about treatment.

Benefits[edit | edit source]

The use of ePROs has several benefits. Firstly, it can improve the accuracy of data collection by reducing the risk of data entry errors. Secondly, it can increase patient engagement by allowing patients to report their health status in their own words. Thirdly, it can facilitate the collection of data in real-time, which can be particularly useful in monitoring chronic conditions.

Challenges[edit | edit source]

Despite these benefits, there are also challenges associated with the use of ePROs. These include the need for technical infrastructure and support, the potential for data privacy issues, and the need for training for both patients and healthcare providers.

Future Directions[edit | edit source]

As technology continues to evolve, it is likely that the use of ePROs will continue to increase. Future research is needed to explore the potential benefits and challenges of ePROs in different healthcare settings and patient populations.

See Also[edit | edit source]

References[edit | edit source]

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD